Immunotherapy for Breast Cancer Treatment.
Antibodies
Breast cancer
Immunotherapy
Journal
Iranian biomedical journal
ISSN: 2008-823X
Titre abrégé: Iran Biomed J
Pays: Iran
ID NLM: 9814853
Informations de publication
Date de publication:
08 Mar 2021
08 Mar 2021
Historique:
entrez:
16
3
2021
pubmed:
17
3
2021
medline:
17
3
2021
Statut:
aheadofprint
Résumé
Breast cancer, as a heterogeneous disease, includes a wide range of pathological and clinical behaviors. Current treatment protocols, including radiotherapy, chemotherapy, and hormone replacement therapy, are mainly associated with poor response and high rate of recurrence. Therefore, more efforts are needed to develop alternative therapies for this type of cancer. Immunotherapy, as a novel strategy in cancer treatment, has a potential in treating breast cancer patients. Although breast cancer has long been considered problematic to treat with immunotherapy, as it is immunologically "cold," numerous newer preclinical and clinical reports now recommend that immunotherapy has the capability to treat breast cancer patients. In this review, we highlight the different immunotherapy strategies in breast cancer treatment.
Identifiants
pubmed: 33724757
doi: 10.29252/ibj.25.3.140
pmc: PMC8183391
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
140-56Références
N Engl J Med. 2007 Jul 5;357(1):39-51
pubmed: 17611206
J Natl Compr Canc Netw. 2015 Dec;13(12):1475-85
pubmed: 26656517
Biotechnol Adv. 2015 Dec;33(8):1868-77
pubmed: 26523780
J Steroid Biochem Mol Biol. 1997 Mar;60(5-6):269-76
pubmed: 9219917
J Clin Oncol. 2019 Sep 1;37(25):2189-2192
pubmed: 31157582
Br J Cancer. 2006 Jan 30;94(2):259-67
pubmed: 16404427
Bioorg Med Chem Lett. 2016 Mar 15;26(6):1542-1545
pubmed: 26898815
Bioconjug Chem. 2010 Jan;21(1):5-13
pubmed: 19769391
Mol Med. 2013 Jan 22;18:1473-9
pubmed: 23196784
Cancer Treat Res. 2018;173:155-165
pubmed: 29349763
Pediatr Blood Cancer. 2016 Jan;63(1):32-8
pubmed: 26305408
Clin Med Insights Pathol. 2015 Dec 21;8:23-31
pubmed: 26740749
Mod Pathol. 2011 Jan;24(1):64-81
pubmed: 20852590
Clin Cancer Res. 2014 Sep 1;20(17):4436-41
pubmed: 24879797
J Clin Oncol. 2012 Jul 20;30(21):2615-23
pubmed: 22665533
Clin Cancer Res. 2009 Oct 15;15(20):6327-40
pubmed: 19808870
Oncotarget. 2015 Oct 20;6(32):33972-81
pubmed: 26378017
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
J Natl Cancer Inst. 2015 Aug 06;107(10):
pubmed: 26251289
Breast J. 2003 Sep-Oct;9(5):361-73
pubmed: 12968955
Trials. 2013 Jul 22;14:228
pubmed: 23876062
Mol Cancer Ther. 2014 Dec;13(12):2991-3000
pubmed: 25253783
Onco Targets Ther. 2013 Jul 09;6:839-52
pubmed: 23874106
Anticancer Agents Med Chem. 2015;15(5):616-30
pubmed: 25511515
Genes Cancer. 2015 Mar;6(3-4):84-105
pubmed: 26000093
Yale J Biol Med. 2014 Dec 12;87(4):491-518
pubmed: 25506283
PLoS One. 2014 Jan 27;9(1):e87377
pubmed: 24475282
J Clin Oncol. 2011 Jan 10;29(2):166-73
pubmed: 21135276
Future Oncol. 2020 Jan;16(3):4439-4453
pubmed: 31829043
Mol Cancer Ther. 2015 Mar;14(3):692-703
pubmed: 25589493
Int J Mol Sci. 2018 Dec 08;19(12):
pubmed: 30544835
Clin Cancer Res. 2011 Mar 15;17(6):1351-61
pubmed: 21138857
Oncologist. 2016 Sep;21(9):1050-62
pubmed: 27401886
J Med Chem. 2006 Jul 13;49(14):4392-408
pubmed: 16821799
Breast. 2015 Nov;24 Suppl 2:S149-53
pubmed: 26299406
J Clin Oncol. 2016 Jul 20;34(21):2460-7
pubmed: 27138582
Cancer J. 2011 Sep-Oct;17(5):343-50
pubmed: 21952285
Curr Opin Obstet Gynecol. 2006 Feb;18(1):24-8
pubmed: 16493256
Bioconjug Chem. 2002 Jan-Feb;13(1):47-58
pubmed: 11792178
Mol Aspects Med. 2006 Oct-Dec;27(5-6):495-502
pubmed: 16973206
Cancer Sci. 2016 Jul;107(7):1039-46
pubmed: 27166974
Bioorg Med Chem Lett. 2016 Oct 15;26(20):5069-5072
pubmed: 27599744
Nutrients. 2012 Jul;4(7):648-75
pubmed: 22852056
Cancer Cell. 2016 Jan 11;29(1):117-29
pubmed: 26766593
Cancer Discov. 2013 Feb;3(2):224-37
pubmed: 23220880
N Engl J Med. 2010 Nov 4;363(19):1812-21
pubmed: 21047225
Curr Med Res Opin. 2013 Jun;29(6):633-42
pubmed: 23574264
J Clin Oncol. 2010 Jun 10;28(17):e279-80; author reply e282-3
pubmed: 20406920
Front Oncol. 2012 Jun 18;2:62
pubmed: 22720269
Oncologist. 2004;9 Suppl 1:2-10
pubmed: 15178810
Int J Mol Sci. 2019 May 09;20(9):
pubmed: 31075880
J Immunother Cancer. 2016 Oct 18;4:59
pubmed: 27777769
Clin Cancer Res. 1999 Oct;5(10):2963-70
pubmed: 10537366
Am J Hematol. 2019 May;94(S1):S3-S9
pubmed: 30680780
Breast Cancer (Auckl). 2018 May 30;12:1178223418774802
pubmed: 29899661
BMC Cancer. 2010 May 21;10:223
pubmed: 20492711
Curr Oncol. 2006 Aug;13(4):141-3
pubmed: 17576455
Clin Cancer Res. 2011 May 15;17(10):3157-69
pubmed: 21372224
J Clin Oncol. 2015 Jan 10;33(2):141-8
pubmed: 25185099
Expert Rev Anticancer Ther. 2008 May;8(5):819-31
pubmed: 18471053
Oncogene. 2015 Oct;34(43):5494-504
pubmed: 25772243
Nature. 2000 Aug 17;406(6797):747-52
pubmed: 10963602
Oncoimmunology. 2015 Oct 29;5(4):e1100790
pubmed: 27141382
Breast Care (Basel). 2012 Aug;7(4):262-6
pubmed: 23904827
J Biol Chem. 1992 Mar 15;267(8):5700-11
pubmed: 1544942
J Immunother. 2003 Jul-Aug;26(4):332-42
pubmed: 12843795
Pathologica. 2020 Mar;112(1):25-41
pubmed: 32202537
Breast Cancer Res Treat. 2011 Jul;128(1):7-21
pubmed: 21499686
BMC Clin Pathol. 2014 Feb 04;14(1):8
pubmed: 24495444
Clin Cancer Res. 2001 Jun;7(6):1490-6
pubmed: 11410481
Mol Cancer. 2015 Oct 06;14:178
pubmed: 26438065
Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):619-626
pubmed: 29593010
J Med Chem. 2014 Dec 26;57(24):10527-43
pubmed: 25431858
J Immunol. 2008 Jul 1;181(1):808-21
pubmed: 18566447
Hum Pathol. 2003 Dec;34(12):1283-9
pubmed: 14691914
Curr Opin Chem Biol. 2009 Jun;13(3):235-44
pubmed: 19414278
Int J Hyperthermia. 2010;26(7):618-24
pubmed: 20849257
Nat Rev Cancer. 2016 Aug 23;16(9):566-81
pubmed: 27550819
Cancer Res. 2008 Nov 15;68(22):9280-90
pubmed: 19010901
Annu Rev Biochem. 1983;52:711-60
pubmed: 6137189
Cell. 2015 Apr 9;161(2):205-14
pubmed: 25860605
Immunity. 2013 Jul 25;39(1):38-48
pubmed: 23890062
Cancer. 2012 Sep 1;118(17):4354-62
pubmed: 22252842
Oncol Lett. 2014 Jun;7(6):2165-2169
pubmed: 24932309
Science. 2013 Dec 20;342(6165):1432-3
pubmed: 24357284
J Hematol Oncol. 2016 Jul 20;9(1):56
pubmed: 27439908
Mol Pharm. 2015 Jun 1;12(6):1813-35
pubmed: 25635711
Breast Cancer (Dove Med Press). 2019 Jan 17;11:53-69
pubmed: 30697064
J Clin Oncol. 2012 Jun 20;30(18):2190-6
pubmed: 22614995
Future Oncol. 2013 Mar;9(3):319-26
pubmed: 23469968
BMC Med. 2015 Sep 04;13:211
pubmed: 26337719
Clin Cancer Res. 2011 Oct 15;17(20):6428-36
pubmed: 22003070
Breast Cancer Res Treat. 2013 Jun;139(3):667-76
pubmed: 23756627
Immunity. 2016 Jun 21;44(6):1444-54
pubmed: 27332733
Mol Ther Oncolytics. 2016 Apr 13;3:16006
pubmed: 27162934
Asian Pac J Cancer Prev. 2005 Jul-Sep;6(3):370-5
pubmed: 16236002
J Leukoc Biol. 2013 Jul;94(1):25-39
pubmed: 23625198
Int J Hyperthermia. 2014 Dec;30(8):531-9
pubmed: 25430985
Drugs. 2017 Sep;77(14):1603-1610
pubmed: 28819740
Oncology. 2015;89(6):337-44
pubmed: 26413775
Indian J Pharmacol. 2011 May;43(3):236-45
pubmed: 21713084
Clin Cancer Res. 2015 Sep 15;21(18):4165-73
pubmed: 26015513
Asian Pac J Cancer Prev. 2012;13(1):367-70
pubmed: 22502702
Expert Rev Vaccines. 2005 Jun;4(3):259-74
pubmed: 16026242
Br J Pharmacol. 2009 May;157(2):220-33
pubmed: 19459844
J Control Release. 2016 Aug 28;236:100-16
pubmed: 27327768
Clin Cancer Res. 2010 Apr 1;16(7):2147-56
pubmed: 20215530
Expert Opin Biol Ther. 2017 Jul;17(7):797-812
pubmed: 28446053
Ther Adv Med Oncol. 2012 Sep;4(5):235-45
pubmed: 22942906
Breast Cancer Res Treat. 2017 Oct;165(3):743-750
pubmed: 28689363
J Clin Oncol. 2015 May 10;33(14):1609-19
pubmed: 25847941
Cancer Immunol Res. 2017 Jul;5(7):516-523
pubmed: 28619968
J Clin Oncol. 2011 Nov 10;29(32):4286-93
pubmed: 21990397
Sci Rep. 2016 Sep 20;6:33658
pubmed: 27645103
Cancer Res. 2015 Aug 15;75(16):3365-72
pubmed: 26113086
FEBS Lett. 2005 Jan 17;579(2):427-32
pubmed: 15642354
J Clin Pathol. 2008 Jul;61(7):856-62
pubmed: 18381381
Clin Cancer Res. 2011 Jul 1;17(13):4550-7
pubmed: 21498393
J Clin Oncol. 2005 Aug 20;23(24):5568-77
pubmed: 16009950
Int J Mol Sci. 2017 Nov 27;18(12):
pubmed: 29186886
N Engl J Med. 2015 Feb 19;372(8):724-34
pubmed: 25693012
J Transl Med. 2016 Jun 10;14(1):173
pubmed: 27286842
Appl Immunohistochem Mol Morphol. 2002 Jun;10(2):152-8
pubmed: 12051634
Curr Opin Pharmacol. 2016 Dec;31:97-103
pubmed: 27883943
N Engl J Med. 2012 Nov 8;367(19):1783-91
pubmed: 23020162
Sci Rep. 2017 Sep 12;7(1):11427
pubmed: 28900139
Nat Biotechnol. 2003 Jul;21(7):778-84
pubmed: 12778055
Oncotarget. 2015 Sep 8;6(26):22496-512
pubmed: 26101915
Lancet Oncol. 2016 Jun;17(6):811-821
pubmed: 27155741
Curr Top Med Chem. 2009;9(16):1494-524
pubmed: 19903166
Int J Cancer. 1993 Dec 2;55(6):891-903
pubmed: 8253525
Int J Oncol. 2009 Oct;35(4):813-21
pubmed: 19724917
JAMA. 2018 Jan 9;319(2):154-164
pubmed: 29318276
J Clin Immunol. 2012 Oct;32(5):1059-70
pubmed: 22526592
Oncoimmunology. 2012 Oct 1;1(7):1104-1110
pubmed: 23170258
JAMA Oncol. 2015 Nov;1(8):1087-95
pubmed: 26291768
Clin Cancer Res. 2019 Apr 15;25(8):2392-2402
pubmed: 30463850
Int J Breast Cancer. 2011;2011:352182
pubmed: 22295219
Clin Breast Cancer. 2011 Oct;11(5):275-82
pubmed: 21729661
Dis Model Mech. 2015 Apr;8(4):337-50
pubmed: 26035842
Nature. 2013 Sep 19;501(7467):365-72
pubmed: 24048069
J Exp Med. 1955 Aug 1;102(2):157-77
pubmed: 13242741
J Clin Oncol. 2011 Apr 1;29(10):1252-60
pubmed: 21383283
Oncotarget. 2016 May 24;7(21):30119-32
pubmed: 27121061
N Engl J Med. 2011 Oct 6;365(14):1273-83
pubmed: 21991949
Cancer Immunol Res. 2016 May;4(5):390-9
pubmed: 26980599